Your browser doesn't support javascript.
loading
From bench to bedside: The promising value of exosomes in precision medicine for CNS tumors.
Wang, Mengjie; Jin, Feng; Tong, Xiaoguang.
Afiliación
  • Wang M; Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300070, China.
  • Jin F; Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital).266042, Qingdao, Shandong, China.
  • Tong X; Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300070, China.
Heliyon ; 10(11): e32376, 2024 Jun 15.
Article en En | MEDLINE | ID: mdl-38961907
ABSTRACT
Exosomes are naturally present extracellular vesicles (EVs) released into the surrounding body fluids upon the fusion of polycystic and plasma membranes. They facilitate intercellular communication by transporting DNA, mRNA, microRNA, long non-coding RNA, circular RNA, proteins, lipids, and nucleic acids. They contribute to the onset and progression of Central Nervous System (CNS) tumors. In addition, they can be used as biomarkers of tumor proliferation, migration, and blood vessel formation, thereby affecting the Tumor Microenvironment (TME). This paper reviews the recent advancements in the diagnosis and treatment of exosomes in various CNS tumors, the promise and challenges of exosomes as natural carriers of CNS tumors, and the therapeutic prospects of exosomes in CNS tumors. Furthermore, we hope this research can contribute to the development of more targeted and effective treatments for central nervous system tumors.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article País de afiliación: China